I agree with Jak44.
This is a blog posting from a week ago, that offers a solution should "some scientists using Luminex® xMAP® Technology encounter proteins that are difficult to couple to microspheres using traditional EDC-NHS chemistry because of difficulty in coupling." (paraphrased for shortness).
This problem you could infer from the blog doesn't happen all that often, so it doesn't look like a revenue raiser and hardly worth a asx notice. If its only to validate ADO technology, you would've thought that would have been validated a long time ago. It's been 10 years after all.
It seems to me that ADO are doing all they can to pump out announcements.
Not helping the sp much but I guess it has stopped it falling.
ADO Price at posting:
9.7¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)